The companies that developed the vaccines and treatments in the covid
pandemic provide very real-life, real-time examples of the questions of protecting
patents as business assets while answering social responsibility concerns.
As the CEO of one of these companies, how would you respond to calls to
share your company’s IP and under what circumstances? How would a Biblical
worldview influence your decisions?
For each thread and reply, analysis must be
supported with a minimum of 2 scholarly sources
other
than the course textbook and provided materials. Each source must be cited in
current APA
format.
Each thread and each reply must include both full citations in a reference list
at the end
of
each post, and short-form in-text citations.
Acceptable
sources include books, legal and business journals, legal cases, the law
(cases,
statutes,
regulations, etc.), the Bible, biblical commentary, etc. Dictionaries and other
web
sources
that lack scholarly support are not acceptable sources. Any sources cited must
be current
to
the issue (e.g., Bible commentaries may by applicable from any age, but
articles discussing
current
legal practices may no longer be relevant after 2 or 5 years).
A
well-developed, complete worldview analysis of the situation requires more than
simply
adding
a Bible verse at the end of the post. Each thread and each reply must include
at least 1
verse
from Scripture, quoted and applied as an integral part of the discussion of the
applicable
issues
in the context of a Biblical worldview.
Consider, for example, the following:
Rowland, C., Rauhala E., & Berger, M. (2021, March 20). Drug companies
defend vaccine monopolies in face of global outcry. The Washington Post.
https://www.washingtonpost.com/business/2021/03/20/covid-vaccine-global-shortages/
D’Eminio, F. (2021, October 11). Moderna has no plans to share its COVID-19
vaccine recipe. AP. https://apnews.com/article/coronavirus-pandemic-technology-business-united-nations-europe-d4aff7ddb273194b312354a57c244ce6
Taylor, A. & Parker, C. (2021, October 27). U.S. drug company Merck to
share license for experimental covid-19 treatment with nonprofit. Washington
Post. https://www.washingtonpost.com/world/2021/10/27/merck-license-ip/
